Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$382K Sell
1,056
-78
-7% -$26.7K 0.03% 218
2026
Q1
$399K Buy
1,134
+177
+18% +$63.1K 0.04% 202
2025
Q4
$313K Sell
957
-68
-7% -$21.6K 0.03% 222
2025
Q3
$289K Hold
1,025
0.02% 245
2025
Q2
$286K Sell
1,025
-12
-1% -$3.4K 0.02% 232
2025
Q1
$323K Sell
1,037
-394
-28% -$116K 0.03% 207
2024
Q4
$373K Sell
1,431
-919
-39% -$273K 0.04% 175
2024
Q3
$695K Sell
2,350
-113
-5% -$37K 0.07% 115
2024
Q2
$770K Buy
2,463
+1,929
+361% +$567K 0.09% 81
2024
Q1
$152K Buy
+534
New +$156K 0.04% 153

Other funds holding AMGN

LRI Investments's AMGN Position: Q2 2026 in Review

LRI Investments reduced its Amgen (AMGN) stake by 6.9% in Q2 2026, selling an estimated $26.7K and leaving 1,056 shares worth $382K. The position accounts for 0.03% of the portfolio, ranked #218.

LRI Investments first reported a position in AMGN in Q1 2024 and has held it in 10 quarters since. The position peaked at $770K in Q2 2024. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • LRI Investments held 1,056 shares of Amgen worth $382K as of Q2 2026.
  • LRI Investments sold 78 Amgen shares in Q2 2026, an estimated $26.7K.
  • Amgen made up 0.03% of LRI Investments's portfolio in Q2 2026, its #218 holding.
  • LRI Investments first reported a position in Amgen in Q1 2024 and has held it in 10 quarters since.
  • LRI Investments's Amgen position peaked at $770K in Q2 2024.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.